162 related articles for article (PubMed ID: 9108462)
1. Detection of peroxisome proliferators using a reporter construct derived from the rat acyl-CoA oxidase promoter in the rat liver cell line H-4-II-E.
Lee MJ; Gee P; Beard SE
Cancer Res; 1997 Apr; 57(8):1575-9. PubMed ID: 9108462
[TBL] [Abstract][Full Text] [Related]
2. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene.
Varanasi U; Chu R; Huang Q; Castellon R; Yeldandi AV; Reddy JK
J Biol Chem; 1996 Jan; 271(4):2147-55. PubMed ID: 8567672
[TBL] [Abstract][Full Text] [Related]
3. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures.
Goll V; Alexandre E; Viollon-Abadie C; Nicod L; Jaeck D; Richert L
Toxicol Appl Pharmacol; 1999 Oct; 160(1):21-32. PubMed ID: 10502499
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes.
Ammerschlaeger M; Beigel J; Klein KU; Mueller SO
Toxicol Sci; 2004 Apr; 78(2):229-40. PubMed ID: 14976357
[TBL] [Abstract][Full Text] [Related]
6. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis.
Yeldandi AV; Rao MS; Reddy JK
Mutat Res; 2000 Mar; 448(2):159-77. PubMed ID: 10725470
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferation as a biomarker in environmental pollution assessment.
Cajaraville MP; Cancio I; Ibabe A; Orbea A
Microsc Res Tech; 2003 Jun; 61(2):191-202. PubMed ID: 12740826
[TBL] [Abstract][Full Text] [Related]
10. Peroxisomal proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo.
Bojes HK; Thurman RG
Toxicol Appl Pharmacol; 1994 Jun; 126(2):233-9. PubMed ID: 8209376
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferators: a model for receptor mediated carcinogenesis.
Green S
Cancer Surv; 1992; 14():221-32. PubMed ID: 1330305
[TBL] [Abstract][Full Text] [Related]
12. Molecular toxicology of peroxisome proliferators.
McNae F; Sharma R; Gibson GG
Eur J Drug Metab Pharmacokinet; 1994; 19(3):219-23. PubMed ID: 7867664
[TBL] [Abstract][Full Text] [Related]
13. Transformation of epithelial cells stably transfected with H2O2-generating peroxisomal urate oxidase.
Chu R; Lin Y; Reddy KC; Pan J; Rao MS; Reddy JK; Yeldandi AV
Cancer Res; 1996 Nov; 56(21):4846-52. PubMed ID: 8895731
[TBL] [Abstract][Full Text] [Related]
14. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?
Melnick RL
Environ Health Perspect; 2001 May; 109(5):437-42. PubMed ID: 11401753
[TBL] [Abstract][Full Text] [Related]
15. [Proliferation of peroxisomes and the hepatocarcinogenic process].
Palut D
Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome enzyme modification and oxidative stress in rat by hypolipidemic and antiinflammatory drugs.
Rivero A; Monreal JI; Gil MJ
Rev Esp Fisiol; 1994 Dec; 50(4):259-68. PubMed ID: 7754169
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiles in rat liver slices exposed to hepatocarcinogenic enzyme inducers, peroxisome proliferators, and 17alpha-ethinylestradiol.
Werle-Schneider G; Wölfelschneider A; von Brevern MC; Scheel J; Storck T; Müller D; Glöckner R; Bartsch H; Bartelmann M
Int J Toxicol; 2006; 25(5):379-95. PubMed ID: 16940010
[TBL] [Abstract][Full Text] [Related]
18. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
Perrone CE; Shao L; Williams GM
Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptors: finding the orphan a home.
Green S; Wahli W
Mol Cell Endocrinol; 1994 Apr; 100(1-2):149-53. PubMed ID: 8056148
[TBL] [Abstract][Full Text] [Related]
20. An upstream region of the enoyl-coenzyme A hydratase/3-hydroxyacyl-coenzyme A dehydrogenase gene directs luciferase expression in liver in response to peroxisome proliferators in transgenic mice.
Alvares K; Fan C; Dadras SS; Yeldandi AV; Rachubinski RA; Capone JP; Subramani S; Iannaccone PM; Rao MS; Reddy JK
Cancer Res; 1994 May; 54(9):2303-6. PubMed ID: 8162569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]